A 17-year-old Connecticut student, Leon Wang, identified two FDA-approved lung-scarring drugs that reduced Alzheimers-linked cellular damage in lab-grown brain blood-vessel cells. His research offers a promising new clue into how APOE4 and the TGFβ pathway may contribute to Alzheimers disease, while raising the possibility that existing medicines could eventually be repurposed for brain health.

Alzheimer’s disease remains one of the most difficult neurological disorders to treat, partly because the processes behind it can begin damaging brain cells long before symptoms…

A 17-year-old Connecticut student, Leon Wang, identified two FDA-approved lung-scarring drugs that reduced Alzheimers-linked cellular damage in lab-grown brain blood-vessel cells.…